Shandong Weigao Group Medical Polymer Co Ltd ($1066) - buy or sell? Stock discussion, ideas, forum

Shandong Weigao Group Medical Polymer Co Ltd

Shandong Weigao Group Medical Polymer Company Limited, through its subsidiaries, researches and develops, produces, and sells single-use aseptic polymer medical products.

Industry: Healthcare-Products

Ticker	Exchange	ISIN	Name
$1066	HKEx Main Board	CNE100000171	Code: 1066

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 1066 stock

Share your investment idea or question on Shandong Weigao Group Medical Polymer Co Ltd stock:

Latest twits on Shandong Weigao Group Medical Polymer Co Ltd (1066)

No twits yet. Be the first to post!

Have a question about 1066? Ask and other investors will be eager to help you.

Have an idea about 1066? Share it with other investors.

Shandong Weigao Group Medical Polymer Co Ltd news

22/03/2017 Shandong Weigao Group Medical Polymer Co Ltd revenue growth accelerated from 12.1% in FY2015 to 13.7% in FY2016

22/03/2016 Shandong Weigao Group Medical Polymer Co Ltd CAPEX jumped on 76.2% in 2015 and Revenue jumped on 12.1%

Shandong Weigao Group Medical Polymer Co Ltd stock price chart

Shandong Weigao Group Medical Polymer Co Ltd financials

mln. CNY	FY2010	FY2011	FY2012

Revenue	2,463	3,181	3,689
EBITDA	790.5	996.0	1,050
Net income	799.1	3,462	996.5
CAPEX	350.1	1,325	959.3
Debt	114.7	84.012	0.000
Cash	628.2	1,851	1,298

Shandong Weigao Group Medical Polymer Co Ltd news

About Shandong Weigao Group Medical Polymer Co Ltd

Shandong Weigao Group Medical Polymer Company Limited, through its subsidiaries, researches and develops, produces, and sells single-use aseptic polymer medical products.